| AKT | Protein kinase B | LUSC | Lung squamous cell carcinoma |
| ALK | Anaplastic lymphoma kinase | MAPK | Mitogen-activated protein kinase |
| AMPK | AMP-activated protein kinase | MDM2 | Mouse double minute 2 homolog |
| AT1 | Alveolar type 1 | MDMX | Mouse double minute X |
| AT2 | Alveolar type 2 | mRNA | Messenger RNA |
| ATM | Ataxia telangiectasia mutated | mTOR | Mammalian target of rapamycin |
| ATR | Ataxia telangiectasia and Rad3-related protein | NGS | Next-generation sequencing |
| CDKN2A | Cyclin-dependent kinase inhibitor 2A | NSCLC | Non-small-cell lung cancer |
| CTD | C-terminal domain | OD | Oligomerization domain |
| ctDNA | Circulating tumor DNA | p53RE | p53-response elements |
| DBD | DNA-binding domain | PARP | Poly-ADP ribose polymerase |
| DLL3 | Delta-like ligand 3 | PD-1 | Programmed cell death protein 1 |
| DNA | Deoxyribonucleic acid | PD-L1 | Programmed cell death 1 ligand 1 |
| DNMT | DNA methyltransferase | PI3K | Phosphatidylinositol 3-kinase |
| EGFR | Epidermal growth factor receptor | PRD | Proline-rich domain |
| FLp53 | Full-length p53 | PTEN | Phosphatase and tensin homolog |
| GOF | Gain of function | Rap1A | Ras-associated protein 1A |
| HDAC | Histone deacetylase | Rb1 | Retinoblastoma 1 protein |
| ICIs | Immune checkpoint inhibitors | RhoC | Ras homolog family member C |
| JNK | c-Jun N-terminal kinase | SCLC | Small-cell lung cancer |
| LC | Lung cancer | TAD | Transactivation domain |
| LOF | Loss of function | YAP | Yes-associated protein |
| LUAD | Lung adenocarcinoma |